Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 3,392 shares at $134.15 ($455K) on 2019-08-08, disclosed to the SEC on 2019-08-12.
Seasonal sale ($455k) by Director — this insider has traded HAE in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.15 | 1,696 | $228K | 50.0% |
| 2 | $134.15 | 1,696 | $228K | 50.0% |
| Total | $134.15 avg | 3,392 | $455K | 100% |
| Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |
| HAE | SELL | 2017-04-27 | $343K | — | Filing → |